IRIS Institutional Research Information System - OPENBS Open Archive UniBS

FIORENTINI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.602
AS - Asia 3.011
EU - Europa 2.905
SA - Sud America 600
Continente sconosciuto - Info sul continente non disponibili 363
AF - Africa 79
OC - Oceania 6
Totale 13.566
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.479
CN - Cina 1.031
SG - Singapore 1.026
IT - Italia 607
UA - Ucraina 529
BR - Brasile 490
PL - Polonia 396
DE - Germania 332
HK - Hong Kong 288
FI - Finlandia 250
FR - Francia 241
VN - Vietnam 221
GB - Regno Unito 164
IN - India 114
RU - Federazione Russa 105
TR - Turchia 98
IE - Irlanda 97
BD - Bangladesh 67
CA - Canada 55
AR - Argentina 41
MX - Messico 36
BE - Belgio 32
ZA - Sudafrica 29
SE - Svezia 28
IQ - Iraq 27
CZ - Repubblica Ceca 24
ID - Indonesia 22
LU - Lussemburgo 20
EC - Ecuador 19
NL - Olanda 19
JP - Giappone 18
ES - Italia 17
IR - Iran 15
PK - Pakistan 15
NG - Nigeria 12
VE - Venezuela 11
CO - Colombia 10
UZ - Uzbekistan 10
MA - Marocco 9
AT - Austria 8
EG - Egitto 8
CL - Cile 7
JO - Giordania 7
PE - Perù 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
EU - Europa 6
KE - Kenya 6
PA - Panama 6
AU - Australia 5
CR - Costa Rica 5
JM - Giamaica 5
KR - Corea 5
PH - Filippine 5
SA - Arabia Saudita 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
KG - Kirghizistan 4
LT - Lituania 4
PS - Palestinian Territory 4
PY - Paraguay 4
AL - Albania 3
BG - Bulgaria 3
CH - Svizzera 3
ET - Etiopia 3
HU - Ungheria 3
IL - Israele 3
OM - Oman 3
PT - Portogallo 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
AM - Armenia 2
AZ - Azerbaigian 2
BB - Barbados 2
CY - Cipro 2
DZ - Algeria 2
GR - Grecia 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
NI - Nicaragua 2
NP - Nepal 2
TJ - Tagikistan 2
AO - Angola 1
BF - Burkina Faso 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
LB - Libano 1
MN - Mongolia 1
MQ - Martinica 1
NO - Norvegia 1
SI - Slovenia 1
Totale 13.204
Salva come PNG Salva come JPEG
Città #
Singapore 569
Fairfield 546
Ashburn 521
Woodbridge 482
Jacksonville 392
Warsaw 392
Houston 322
Hong Kong 286
Chandler 266
Brescia 254
San Jose 249
The Dalles 216
Cambridge 207
Beijing 201
Seattle 200
Ann Arbor 194
Wilmington 191
Princeton 180
New York 179
Los Angeles 161
Helsinki 146
Chicago 139
Nanjing 134
Council Bluffs 124
Dublin 97
Lauterbourg 94
Buffalo 85
Dallas 84
Istanbul 76
Ho Chi Minh City 73
Columbus 72
Dearborn 70
Munich 66
Milan 52
Salt Lake City 49
Nanchang 48
Santa Clara 48
Shanghai 47
Moscow 44
Hanoi 43
Des Moines 41
Hebei 39
Shenyang 39
São Paulo 39
Tianjin 38
San Diego 33
Elk Grove Village 31
London 31
San Francisco 31
Jinan 30
Lancaster 29
Brussels 28
Changsha 27
Pune 26
Redondo Beach 26
Orem 25
Tampa 24
Turku 24
Jiaxing 23
San Mateo 22
Secaucus 22
Brooklyn 21
Dong Ket 20
Frankfurt am Main 20
Phoenix 20
Poplar 20
Denver 19
Kunming 19
Toronto 19
Johannesburg 18
Hangzhou 17
Mexico City 17
San Donà Di Piave 16
Tokyo 16
Guangzhou 15
Brno 14
Rio de Janeiro 14
Verona 14
Ardabil 13
Dudelange 13
Leawood 13
Miami 13
Rome 13
Sterling 13
Lappeenranta 12
Montreal 12
Abuja 11
Belo Horizonte 11
Brasília 11
Charlotte 11
Jakarta 11
Manchester 11
Chennai 10
Da Nang 10
Ningbo 10
Atlanta 9
Augusta 9
Boston 9
Haiphong 9
Kocaeli 9
Totale 8.769
Salva come PNG Salva come JPEG
Nome #
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 599
Modulation by chronic stress and ketamine of ionotropic AMPA/NMDA and metabotropic glutamate receptors in the rat hippocampus 347
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 299
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 249
The "in situ" proximity ligation assay to probe protein-protein interactions in intact tissues 230
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 227
Immunotherapy failure in adrenocortical cancer: where next? 226
Social networks and health status in the elderly: the ‘ANZIANI IN-RETE’ population-based study 213
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 208
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 205
MURC/cavin-4 is co-expressed with Caveolin-3 in rhabdomyosarcoma tumors and its silencing prevents myogenic differentiation in the human embryonal RD cell line 200
The D3 dopamine receptor: From structural interactions to function. 193
Palbociclib inhibits proliferation of human adrenocortical tumor cells 190
Kainate Receptor RNA Editing is Markedly Altered by Acute Spinal Cord Injury. 187
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in L-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease 180
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease 178
Receptor Heteromers in Parkinson's Disease and L-DOPA-Induced Dyskinesia 175
Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation. 168
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity 168
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 166
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 164
Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterization. 161
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer 155
Ormoni Anteroipofisari 152
Exploring pre-degenerative alterations in humans using induced pluripotent stem cell-derived dopaminergic neurons 150
Chronic glutamate treatment selectively modulates AMPA RNA editing and ADAR expression and activity in primary cortical neurons 149
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 148
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 147
Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function 146
The NMDA/D1 receptor complex as a new target in drug development 143
Role of receptor heterodimers in the development of L-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease. 139
Generation of two human induced pluripotent stem cell lines, UNIBSi012-A and UNIBSi013-A, from two patients with treatment-resistant depression 139
CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction 138
Dopamine D3 receptors are critically involved in the neurotrophic effects of cocaine and nicotine on the mouse mesencephalic dopaminergic neurons 138
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas 133
Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization 133
The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. 133
Role of dopamine D3R and acetylcholine nicotinic receptor interaction in the regulation of dopaminergic neurons function. 133
The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes 132
In-vivo silencing of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease 131
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 131
Establishment and characterization of induced pluripotent stem cell (iPSCs) line UNIBSi014-A from a healthy female donor 131
Nerve growth factor regulates dopamine D2 receptor expression in prolactinoma cell lines via p75NGFR-mediated activation of nuclear factor-kB. 130
Group-II metabotropic glutamate receptors negatively modulate NMDA transmission at striatal cholinergic terminals: Role of P/Q-type high voltage activated Ca++ channels and endogenous dopamine 130
Down-regulation of the D1R/Shp-2/Erk1/2 pathway ameliorates L-DOPA-induced dyskinesia in the 6-Hydroxy-Dopamine rat model of Parkinson's disease. 127
D1 receptor properties are modulated by its oligomerization with NMDA receptors 126
Role of dopamine D3R/nAChR heterodimeric complex in the regulation of dopaminergic neurons function. 122
D1 receptor signalling in basal ganglia function and dysfunctions. 122
Eterodimerizzazione tra recettori dopaminergici D1 e D3: implicazioni funzionali e farmacologiche 121
Knock-down of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of parkinson's disease. 120
Role of dopamine D1 receptor and phosphatase Shp-2 in L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. 118
Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract 117
Dopamine D1R activation triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 117
Dopamine-induced Erk activation in striatal neurons is mediated by a direct interaction between the D1 receptor and the tyrosine phosphatase Shp-2. 117
D1 and D3 dopamine receptors form heterooligomers and cointernalization after paired activation of both receptors 116
Neurotrophic effects of cocaine on mouse mesencephalic dopaminergic neurons are mediated by dopamine D3 receptors 116
Molecular mechanisms underlying dopamine D1R-dependent activation of striatal Erk1/2 in L-DOPA induced dyskinesia in a rat model of Parkinson’s disease. 116
Role of D1 and D3 dopamine receptor heterodimerization in the regulation of the receptor signalling 116
The Shp-2 tyrosine phosphatase interacts with the dopamine D1 receptor and triggers D1-mediated Erk signalling in striatal neurons. 114
Phenotype changes of prolactinomas 113
Dopamine D1R activation modulates intracellular signalling and triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 113
Dopamine agonists produce neurotrophic effects on mesencephalic dopaminergic neurons via dopamine D3 receptor activation 112
Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson's disease patients carrying the LRRK2 G2019S mutation 110
Functional implications of dopamine D1 and D3 receptor heterodimerization 109
miR-9-5p is involved in the rescue of stress-dependent dendritic shortening of hippocampal pyramidal neurons induced by acute antidepressant treatment with ketamine 107
17-β-estradiol potentiates the neurotrophic and neuroprotective effects mediated by the dopamine D3/acetylcholine nicotinic receptor heteromer in dopaminergic neurons 105
Oligomeric assembly of dopamine D1 and glutamate NMDA receptors: molecular mechanisms and functional implications 102
Interactions of Dopamine D1 receptors with D3 receptors and glutamate NMDA receptors 101
Downregulation of dopamine D1/ glutamate NMDA receptor complexes in L-DOPA-induced dyskinesia in the rat 100
In-vitro Approaches to Investigate the Detrimental Effect of Light on Dopaminergic Neurons 99
Regulation of D1 receptor signalling by direct interaction with the protein tyrosine phosphatase SHP-2 98
Induced pluripotent stem cells for defining Parkinsonian patient subtypes: a further step toward precision medicine 98
Structural Plasticity of Dopaminergic Neurons Requires the Activation of the D3R-nAChR Heteromer and the PI3K-ERK1/2/Akt-Induced Expression of c-Fos and p70S6K Signaling Pathway 97
Ormoni anteroipofisari 95
Frailty and cognitive impairment in elderly patients: miRNAs as new biomarkers (MATCH-In project) 94
Recent Advances in Dopamine D3 Receptor Heterodimers: Focus on Dopamine D3 and D1 Receptor–Receptor Interaction and Striatal Function 93
Oligomerization and trafficking of the human dopamine transporter: mutational analysis identifies critical domains important for the functional expression of the transporter. 91
Dendritic remodeling of hippocampal pyramidal neurons, induced by chronic stress and fast-acting antidepressant ketamine, involves miR-9-5p 91
Loss of Synaptic D1 Dopamine/N-Methyl-D-aspartate Glutamate Receptor Complexes in L-DOPA-Induced Dyskinesia in the Rat. 90
Regulation of G-protein coupled receptor trafficking by receptor-receptor interaction 88
G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2 88
Receptor dimerization and the regulation of neuronal function 86
Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate NMDA receptors 86
Central nervous system interaction and crosstalk between nAChRs and other ionotropic and metabotropic neurotransmitter receptors 85
Identification and characterization of two Nf-kB binding sites in the human dopamine d2 receptor promotor 85
Farmacologia degli ormoni anteroipofisari 85
Identification and characterization of two nuclear factor-kappaB sites in the regulatory region of the dopamine D2 receptor. 84
Meccanismo molecolari e cellulari nel Morbo di Parkinson 83
Downregulation of dopamine D1/NMDA receptor complexes in the post synaptic densities of dyskinetic rats 81
Generation of human induced pluripotent stem cell lines derived from three Noonan syndrome patients from a single family carrying the heterozygous PTPN11 c.188 A > G (p.Y63C) mutation 79
MicroRNAs in frailty associated cognitive impairment MATCH In. 79
Role of D1 and D3 dopamine receptor heterodimerization in the regulation of receptor trafficking and function 78
Oligomerization with NMDA receptor as a novel regulatory mechanism of D1 receptor function 77
microRNAs as possible biomarkers of frailty and cognitive impairment: the MATCH-In project 76
Growth factors in pituitary tumors 75
Oligomerization of dopamine D1 and glutamate NMDA receptors: a new mechanism regulating striatal function” 75
microRNAs as new biomarkers in frailty associated with cognitive impairment in elderly patients (MATCH-In project) 75
Functional impact of CYFIP2 RNA Editing on actin regulation, axon growth, and spinogenesis 64
The Potential Role of miRNAs in Cognitive Frailty 62
Dysregulation of glutamatergic and GABAergic neurons in Treatment-Resistant Depression: Insights from patient-derived neurons 59
Totale 13.447
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.387
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.387
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022663 0 0 49 24 6 14 90 42 42 102 68 226
2022/2023756 114 9 18 58 70 219 3 75 118 18 23 31
2023/2024748 55 10 69 71 33 170 27 23 137 26 20 107
2024/20252.126 15 20 9 208 169 180 133 56 168 339 604 225
2025/20263.595 305 459 293 548 359 256 523 177 230 281 102 62
2026/2027421 136 144 141 0 0 0 0 0 0 0 0 0
Totale 13.566